Candidate HIV/AIDS vaccines-Reference-Cited by-同舟云学术

Candidate HIV/AIDS vaccines

Published:2003-01 Issue:2 Volume:17 Page:147-156
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Francis Donald P,Heyward William L,Popovic Vladimir,Orozco-Cronin Patti,Orelind Karin,Gee Carolyn,Hirsch Adrian,Ippolito Tina,Luck Aimee,Longhi Michael,Gulati Vineeta,Winslow Nathan,Gurwith Marc,Sinangil Faruk,Berman Phillip W

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference14 articles.

1. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160

2. Protection of MN-rgp120-Immunized Chimpanzees from Heterologous Infection with a Primary Isolate of Human Immunodeficiency Virus Type 1

3. Recombinant HIV-1 Glycoprotein 120 Induces Distinct Types of Delayed Hypersensitivity in Persons With or Without Pre-Existing Immunologic Memory

4. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

5. Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120.

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is a COVID-19 Vaccine Likely to Make Things Worse?;Vaccines;2020-12-14

2. A Zigzag but Upward Way to Develop an HIV-1 Vaccine;Vaccines;2020-09-08

3. COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds;Journal of Virology;2020-08-17

4. Immune Correlate-Guided HIV Vaccine Design;Cell Host & Microbe;2018-07

5. HIV Vaccine for Prevention and Cure, A Mission Possible;Reviews on Recent Clinical Trials;2016-10-04